Viral antigen
Project Summary
A series of animations for a first-in-class EBV cancer inhibitor.
About the project

Nascent was asked to highlight the science behind a breakthrough therapeutic approach that targets viral antigens in cancer cells. The goal of any MOA animation is to make a complex molecular mechanism accessible to all: researchers, clinicians, investors, and patients. And with each Oncology project we work on, it's so important that this goal is not only met, but exceeded.  The message of any MOA should be clear:  This is how a therapy works, and this is why it holds promise.

Viral antigen
No items found.